Syndax Pharmaceuticals, Inc.
USD21.78
+0.47 (+2.21%)
CEO
Michael A. Metzger
IPO Date
2016-03-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$21.20
Prev. Close
$21.31
Day Low
$20.86
Day High
$22.05
52W Low
$8.59
52W High
$25.59
Market Cap
$1.93B
Volume
4.23M
| 34,280 |
| $18.00 |
| 12 Jun 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | M-Exempt | Acquired | 31,235 | $13.82 |
| 12 Jun 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | S-Sale | Disposed | 31,235 | $18.14 |
| 12 Jun 2026 | Botwood Nicholas A.J. | Head of R&D, CMO | M-Exempt | Acquired | 31,235 | $13.82 |
| 2 Jun 2026 | Goldan Keith A. | Chief Financial Officer | S-Sale | Disposed | 1,177 | $18.99 |
| 2 Jun 2026 | Metzger Michael A | director, officer: Chief Executive Officer | S-Sale | Disposed | 6,847 | $18.99 |
| 10 Feb 2026 | Metzger Michael A | director, officer: Chief Executive Officer | S-Sale | Disposed | 17,159 | $21.03 |
| 10 Feb 2026 | Goldan Keith A. | Chief Financial Officer | S-Sale | Disposed | 3,410 | $21.03 |
| 6 Feb 2026 | Metzger Michael A | director, officer: Chief Executive Officer | A-Award | Acquired | 73,000 | $0.00 |